K.J. Harrison & Partners Inc Has $4.85 Million Stake in CVS Health Corporation (CVS)
K.J. Harrison & Partners Inc grew its holdings in CVS Health Corporation (NYSE:CVS) by 11.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 60,255 shares of the pharmacy operator’s stock after purchasing an additional 5,964 shares during the period. CVS Health Corporation makes up about 1.9% of K.J. Harrison & Partners Inc’s portfolio, making the stock its 9th biggest position. K.J. Harrison & Partners Inc’s holdings in CVS Health Corporation were worth $4,848,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Mercer Capital Advisers Inc. bought a new position in shares of CVS Health Corporation in the 1st quarter valued at $118,000. TB Alternative Assets Ltd. bought a new stake in CVS Health Corporation during the 2nd quarter worth $121,000. Gemmer Asset Management LLC grew its position in CVS Health Corporation by 15.3% during the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after acquiring an additional 200 shares during the last quarter. SRS Capital Advisors Inc. grew its position in CVS Health Corporation by 48.2% during the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after acquiring an additional 734 shares during the last quarter. Finally, Nadler Financial Group Inc. bought a new stake in CVS Health Corporation during the 2nd quarter worth $202,000. Institutional investors own 81.49% of the company’s stock.
In other news, CFO David M. Denton sold 237,078 shares of CVS Health Corporation stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $79.65, for a total transaction of $18,883,262.70. Following the completion of the transaction, the chief financial officer now directly owns 141,096 shares in the company, valued at $11,238,296.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Jonathan C. Roberts sold 85,743 shares of CVS Health Corporation stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $83.14, for a total transaction of $7,128,673.02. Following the transaction, the chief operating officer now owns 119,555 shares of the company’s stock, valued at $9,939,802.70. The disclosure for this sale can be found here. Insiders have sold 716,625 shares of company stock valued at $58,318,431 over the last quarter. Company insiders own 0.61% of the company’s stock.
Shares of CVS Health Corporation (CVS) opened at 80.90 on Friday. CVS Health Corporation has a one year low of $69.30 and a one year high of $88.92. The company has a market capitalization of $82.24 billion, a price-to-earnings ratio of 16.12 and a beta of 0.92. The firm’s 50-day moving average price is $79.69 and its 200-day moving average price is $79.05.
CVS Health Corporation (NYSE:CVS) last released its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The firm had revenue of $45.69 billion during the quarter, compared to analyst estimates of $45.36 billion. During the same period last year, the business earned $1.32 earnings per share. The business’s revenue was up 4.5% on a year-over-year basis. Analysts anticipate that CVS Health Corporation will post $5.88 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.47%. CVS Health Corporation’s payout ratio is 39.92%.
CVS has been the topic of a number of research reports. Jefferies Group LLC restated a “hold” rating and set a $82.00 price objective on shares of CVS Health Corporation in a research report on Friday, June 9th. Cowen and Company restated an “outperform” rating and set a $86.00 price objective on shares of CVS Health Corporation in a research report on Tuesday, June 13th. Royal Bank Of Canada initiated coverage on CVS Health Corporation in a research report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price objective on the stock. Leerink Swann set a $90.00 price objective on CVS Health Corporation and gave the stock a “buy” rating in a research report on Tuesday, June 27th. Finally, Robert W. Baird restated an “outperform” rating and set a $90.00 price objective on shares of CVS Health Corporation in a research report on Monday, August 14th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have given a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $89.56.
CVS Health Corporation Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.